These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32309294)

  • 1. Morphological Features of Minimal Change Disease and Focal Segmental Glomerulosclerosis Using Repeat Biopsy and Parietal Epithelial Cell Marker.
    Suzuki T; Kohatsu K; Han W; Watanabe S; Yahagi K; Nakata M; Ueno T; Ichikawa D; Imai N; Shirai S; Koike J; Shibagaki Y
    Kidney Dis (Basel); 2020 Mar; 6(2):119-124. PubMed ID: 32309294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin G/albumin staining in tubular protein reabsorption droplets in minimal change disease and focal segmental glomerulosclerosis.
    Bu L; Mirocha J; Haas M
    Nephrol Dial Transplant; 2021 May; 36(6):1016-1022. PubMed ID: 32191308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis.
    Pérez V; López D; Boixadera E; Ibernón M; Espinal A; Bonet J; Romero R
    BMC Nephrol; 2017 Feb; 18(1):49. PubMed ID: 28158993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
    Alshami A; Roshan A; Catapang M; Jöbsis JJ; Kwok T; Polderman N; Sibley J; Sibley M; Mammen C; Matsell DG;
    Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synaptopodin immunoexpression in steroid-responsive and steroid-resistant minimal change disease and focal segmental glomerulosclerosis.
    Wagrowska-Danilewicz M; Danilewicz M
    Nefrologia; 2007; 27(6):710-5. PubMed ID: 18336100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline characteristics and long-term outcomes of steroid-resistant nephrotic syndrome in children: impact of initial kidney histology.
    Watanabe Y; Fujinaga S; Endo A; Endo S; Nakagawa M; Sakuraya K
    Pediatr Nephrol; 2020 Dec; 35(12):2377-2381. PubMed ID: 32964318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults.
    Tune BM; Mendoza SA
    J Am Soc Nephrol; 1997 May; 8(5):824-32. PubMed ID: 9176855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary peptide profiling to differentiate between minimal change disease and focal segmental glomerulosclerosis.
    Pérez V; Ibernón M; López D; Pastor MC; Navarro M; Navarro-Muñoz M; Bonet J; Romero R
    PLoS One; 2014; 9(1):e87731. PubMed ID: 24498182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis.
    Garin EH; Mu W; Arthur JM; Rivard CJ; Araya CE; Shimada M; Johnson RJ
    Kidney Int; 2010 Aug; 78(3):296-302. PubMed ID: 20485332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The direction and role of phenotypic transition between podocytes and parietal epithelial cells in focal segmental glomerulosclerosis.
    Sakamoto K; Ueno T; Kobayashi N; Hara S; Takashima Y; Pastan I; Matsusaka T; Nagata M
    Am J Physiol Renal Physiol; 2014 Jan; 306(1):F98-F104. PubMed ID: 24154691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Urine Proteomic Biomarkers for Focal Segmental Glomerulosclerosis and Minimal Change Disease.
    Chebotareva NV; Vinogradov A; Brzhozovskiy AG; Kashirina DN; Indeykina MI; Bugrova AE; Lebedeva M; Moiseev S; Nikolaev EN; Kononikhin AS
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Prospective Study on Complement Activation Distinguishes Focal Segmental Glomerulosclerosis from Minimal Change Disease.
    Cambier A; Patey N; Royal V; Gougeon F; Genest DS; Brachemi S; Bollée G; Merlen C; Bonnefoy A; Lapeyraque AL; Troyanov S
    Kidney Int Rep; 2024 Mar; 9(3):661-670. PubMed ID: 38481495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult primary nephrotic syndrome trends by race: a diminished frequency of focal segmental glomerulosclerosis in non-black patients.
    Mbakop C; DeVita MV; Wahl SJ; Bijol V; Rosenstock JL
    Int Urol Nephrol; 2021 Apr; 53(4):719-724. PubMed ID: 33200335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary soluble HLA class I antigen in patients with minimal change disease: a predictor of steroid response.
    Park CW; Song HC; Shin YS; Ahn SJ; Kim YS; Kim SY; Choi EJ; Chang YS; Bang BK
    Nephron; 1998; 79(1):44-9. PubMed ID: 9609461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings.
    Pelletier JH; Kumar KR; Engen R; Bensimhon A; Varner JD; Rheault MN; Srivastava T; Straatmann C; Silva C; Davis TK; Wenderfer SE; Gibson K; Selewski D; Barcia J; Weng P; Licht C; Jawa N; Kallash M; Foreman JW; Wigfall DR; Chua AN; Chambers E; Hornik CP; Brewer ED; Nagaraj SK; Greenbaum LA; Gbadegesin RA
    Pediatr Nephrol; 2018 Oct; 33(10):1773-1780. PubMed ID: 29982878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
    Stokes MB; Markowitz GS; Lin J; Valeri AM; D'Agati VD
    Kidney Int; 2004 May; 65(5):1690-702. PubMed ID: 15086908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis.
    Hansrivijit P; Cheungpasitporn W; Thongprayoon C; Ghahramani N
    BMC Nephrol; 2020 Apr; 21(1):134. PubMed ID: 32293308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis.
    Siligato R; Cernaro V; Nardi C; De Gregorio F; Gembillo G; Costantino G; Conti G; Buemi M; Santoro D
    Expert Opin Investig Drugs; 2018 Nov; 27(11):839-879. PubMed ID: 30360670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High incidence of focal segmental glomerulosclerosis in nephrotic syndrome of childhood.
    Srivastava T; Simon SD; Alon US
    Pediatr Nephrol; 1999 Jan; 13(1):13-8. PubMed ID: 10100283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synaptopodin expression in idiopathic nephrotic syndrome of childhood.
    Srivastava T; Garola RE; Whiting JM; Alon US
    Kidney Int; 2001 Jan; 59(1):118-25. PubMed ID: 11135064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.